|
|
|
15 Aug 2007 |
Urigen Pharmaceuticals, Inc. Initiates URG101-104 Phase II Pharmacodynamic Clinical Trial for Painful Bladder Syndrome/Interstitial Cystitis
|
|
14 Aug 2007 |
Oragenics Receives Clinical Hold Letter From FDA
|
|
13 Aug 2007 |
Cipher provides CIP-ISOTRETINOIN regulatory update
|
|
13 Aug 2007 |
Ophthotech raises $36 million; in-licenses two compounds for macular degeneration
|
|
10 Aug 2007 |
Biovail enters into license and development agreement
|
|
10 Aug 2007 |
GSK receives decision from FDA on Advair 500/50 for COPD
|
|
09 Aug 2007 |
DEFLUX(R) significantly reduces urinary tract infections in children with vesicoureteral reflux
|
|
08 Aug 2007 |
Lux granted fast track designation by FDA for LX211 for the treatment of uveitis
|
|
07 Aug 2007 |
Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
|
|
07 Aug 2007 |
CeNeS Licenses New Intravenous Anaesthetic to Ono in Japan
|
|
07 Aug 2007 |
Prana Provides an Update on the Phase IIa Trial of PBT2 in Patients with Alzheimer's Disease
|
|
07 Aug 2007 |
Indevus Announces FDA Approval of SANCTURA(R) XR
|
|
04 Aug 2007 |
Bayer HealthCare and Regeneron initiate Phase 3 global development program for VEGF Trap-Eye in wet age-related macular degeneration (AMD)
|
|
01 Aug 2007 |
Eslax(R) (rocuronium bromide) approved in Japan
|
|
01 Aug 2007 |
Alcon's Treatment of Glaucoma and Ocular Hypertension, TRAVATANZ(TM) Solution, Approved in Japan
|
|
01 Aug 2007 |
EMEA Committee for Orphan Medicinal Products Recommends Orphan Medicinal Product Designation for Lux Biosciences’ LX211 for the Treatment of Uveitis
|
|
31 Jul 2007 |
VIVUS Receives FDA Approval of Evamist NDA
|
|
31 Jul 2007 |
Decision About European Marketing Authorization for Oracea(R) Postponed to 2008
|
|
31 Jul 2007 |
TargeGen Initiates Multi-Center Phase II Clinical Trial Of TG100801, A Topically Applied Kinase Inhibitor In Macular Degeneration Patients
|
|
31 Jul 2007 |
Neurocrine Biosciences In-Licenses Clinical Compound: Valnoctamide Stereoisomers
|
|
28 Jul 2007 |
Gene Logic Drug Candidate Shows Positive In Vivo Test Results
|
|
27 Jul 2007 |
Tranzyme Pharma Initiates Dosing of Patients in a Multi-National Phase IIb Clinical Trial with its Novel Ghrelin Agonist, TZP-101, for Post-Operative Ileus
|
|
27 Jul 2007 |
Mircera approved in European Union for treatment of anaemia related to chronic kidney disease
|
|
26 Jul 2007 |
BioSante Pharmaceuticals Announces Positive Resultsfor its CaP Technology for Use in Aesthetic Medicine
|
|
26 Jul 2007 |
Repros Reports That Patients Exposed to Proellex For Up To Six Months Demonstrated A Benign Endometrium Based On Biopsy
|
|
25 Jul 2007 |
Wyeth Receives Approvable Letter from FDA for PRISTIQ for the Treatment of Vasomotor Symptoms Associated with Menopause
|
|
25 Jul 2007 |
Anika Therapeutics Receives FDA Approval for ELEVESS(TM) Product
|
|
24 Jul 2007 |
BioXell starts Phase IIb European Trial of Elocalcitol in Overactive Bladder
|
|
24 Jul 2007 |
QLT announces fda filing and review of Aczone(TM) labeling supplement for removal of blood screening requirement
|
|
21 Jul 2007 |
Organon's Marketing Authorization Application for sugammadex accepted for review by EMEA
|
|
18 Jul 2007 |
FDA Approves Extina(R) for the Treatment of Seborrheic Dermatitis
|
|
17 Jul 2007 |
Medtronic Receives Approval for First Artificial Disc for the Neck in the United States
|
|
17 Jul 2007 |
ACADIA Pharmaceuticals Earns Milestone on Advancement of Glaucoma Drug Candidate
|
|
14 Jul 2007 |
FDA Accepts Jerini Ophthalmic's IND of JSM 6427 for the Treatment of AMD
|
|
13 Jul 2007 |
Tranzyme Pharma Receives FDA Fast Track Designation for its Novel Ghrelin Agonist, TZP-101, for the Treatment of Severe Gastroparesis
|
|
13 Jul 2007 |
Sucampo Pharmaceuticals Submits Supplemental New Drug Application for Lubiprostone to Treat Irritable Bowel Syndrome With Constipation
|
|
13 Jul 2007 |
Q-Med announces results of North American clinical study of ZUIDEX
|
|
13 Jul 2007 |
Lab International announces positive results from its Growth Hormone Releasing Hormone (GHRH) Phase II trial
|
|
12 Jul 2007 |
Opko Health Initiates Phase 3 Trial of Bevasiranib for the Treatment of AMD
|
|
11 Jul 2007 |
Pipex Pharmaceuticals Acquires Late-Stage Oral Candidate for Dry Age-Related Macular Degeneration (AMD)
|
|
11 Jul 2007 |
Clinical study confirms excellent efficacy of BF-200 ALA in actinic keratosis
|
|
06 Jul 2007 |
EMEA Approves Kamada’s Plans for Phase II / III Clinical Trials of the Aerosolized Form of AAT for the Treatment of Congenital Emphysema
|
|
30 Jun 2007 |
Akorn, Inc. Announces the New Drug Application Filing for Akten(R)
|
|
29 Jun 2007 |
OMRIX Biopharmaceuticals Completes Patient Enrollment in Fibrin Patch Phase 1 Clinical Trial
|
|
27 Jun 2007 |
Kythera Biopharmaceuticals completes enrollment in Phase II actinic keratosis trial
|
|
26 Jun 2007 |
Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia(R) in Children Suffering From Vernal Keratoconjunctivitis
|
|
25 Jun 2007 |
Affymax(R) Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide(TM) for the Treatment of Anemia
|
|
21 Jun 2007 |
Shire in-licenses JUVISTA(R) (human TGFβ3) from Renovo
|
|
21 Jun 2007 |
King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R)
|
|
20 Jun 2007 |
Organon's once-a-month contraceptive ring, NuvaRing(R) completes European authorization
|
| |
|
Results 451 - 500 of 985 |
